What are Monoclonal Antibodies?
Monoclonal antibodies work by preventing the COVID-19 virus from entering your cells. They are proven to decrease severe symptoms, lower your chance of hospitalization by at least 75%, and decrease the risk of you transmitting the virus to others. The FDA has created guidelines for emergency-use authorization (EUA), which details who can receive the infusion. The typical persons who receive the antibodies are:
- at least 12 years old (and weigh more than 88 pounds), those who are over the age of 55 automatically qualify,
- high risk for COVID-19 complications (those who have of asthma, diabetes, high blood pressure, or other long term conditions etc),
- test positive for COVID-19, and have only been having symptoms for less than 10 days
Those who require hospitalization are not candidates for the infusion, but should seek emergent care or call 911 immediately. Infusion centers and healthcare facilities can also use the antibodies in an unvaccinated or immunocompromised patient at increased risk for severe complications after being exposed to someone with COVID-19. We are unable to give preventative infusions, and we will not give the infusion to those who have not tested positive within the last 10 days.
You can receive the antibody infusion at registered infusion centers, emergency rooms, as well as through local and state organizations. Many of those infusions centers will provide the medication at no cost, if you do not have insurance, or will process any insurance for no cost (similar to the Covid-19 vaccine). Any visit at Ally Medical ER will be billed as an Emergency Room visit, and we are unable to provide the care of infusion at no cost. Since we are an Emergency Room, we are unable to take appointments, and we will prioritize over those requiring lifesaving treatments above those requesting monoclonal antibody infusions.
If you are not a candidate for emergent monoclonal antibody infusion at Ally Medical, or you wish to have your infusion covered at no cost, you can find a list of locations carrying this medication at this link:
**Please note that some may require a provider’s order prior to scheduling- please check with your provider if scheduling allows.
If you are a provider here is the ordering template for the infusion centers: https://strac.org/ric
Sotrovimab FAQ (Omicron Variant): https://www.fda.gov/media/149534/download
Regeneron FAQ (Delta Variant): https://www.regeneron.com/downloads/treatment-covid19-eua-fact-sheet-for-patient.pdf
Bamlamivimab & Etesevimab FAQ (Alpha Variant): http://pi.lilly.com/eua/bam-and-ete-eua-factsheet-patient.pdf
Should you wish to receive a dose of monoclonal antibodies, remember that it is a decision that will be made between you and your doctor. Any physician, including those at Ally Medical will assess your risk factors and decide if the infusion is right for you. Once you have decided that the infusion is right for you, you can anticipate the following steps:
- You will sign a consent to receive the monoclonal antibody infusion.
- A nurse or qualified person will start an IV in your arm and may draw blood depending on what the physician deems necessary.
- You may receive medications by mouth or by IV to prevent potential side effects.
- The nurse will start the antibody infusion and it will last between 20 minutes and 1 hour.
- You will be monitored for one hour after the infusion to check for signs of reaction.
- You can anticipate for all of these steps to typically take around 3 hours at Ally Medical.
If you are not vaccinated, after you receive the infusion, you must wait 90 days before you can receive a COVID-19 vaccine. This is similar to the time you must wait to be vaccinated after being infected with COVID-19.